When you have HIV/AIDS, you’re at higher risk of infections your body would normally be able to fight off. They can also be more severe, more frequent, or both. These infections are called ...

From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope ...

Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.

To earn CME related to this news article, click here. March 27, 2009 — The US Centers for Disease Control (CDC), National Institutes of Health (NIH), and the HIV Medicine Association of the Infectious ...

In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...

HIV is the virus that causes AIDS. The illness known as HIV/AIDS happens in three stages: acute HIV infection, chronic HIV infection, and AIDS. But the phrase “chronic HIV infection” isn’t simply the ...

Purpose: The rationale for recent changes in guidelines for the prevention of opportunistic infections (OIs) in HIV-infected persons is discussed. Summary: The epidemiology of AIDS has changed ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. This article first appeared in The Checkup, MIT Technology Review’s weekly biotech ...